Nuritas
Nuritas is an ingredient discovery company that leverages its AI-powered platform, the Nuritas Magnifier, to identify, unlock, clinically test, and patent peptides derived from nature. These peptides are designed as precise ingredients to enhance the efficacy of various products, aiming to make them safer, healthier, and greener. The company's core business model revolves around creating and commercializing these patented bioactive peptides for applications in dietary supplements, functional food & beverages, medical foods, and cosmetics. Nuritas has achieved significant scientific milestones, including identifying over 8 million natural peptides and boasting an 80% success rate in predicting peptide efficacy. They have also secured 56 patents. The company has key products like PeptiStrong®, PeptiSleep™, and PeptiYouth™ in its portfolio.
Nuritas
Nuritas is an ingredient discovery company that leverages its AI-powered platform, the Nuritas Magnifier, to identify, unlock, clinically test, and patent peptides derived from nature. These peptides are designed as precise ingredients to enhance the efficacy of various products, aiming to make them safer, healthier, and greener. The company's core business model revolves around creating and commercializing these patented bioactive peptides for applications in dietary supplements, functional food & beverages, medical foods, and cosmetics. Nuritas has achieved significant scientific milestones, including identifying over 8 million natural peptides and boasting an 80% success rate in predicting peptide efficacy. They have also secured 56 patents. The company has key products like PeptiStrong®, PeptiSleep™, and PeptiYouth™ in its portfolio.
TL;DR
What they do: AI-driven discovery and commercialization of natural bioactive peptides for food, supplements, medical foods and cosmetics
Founded: 2014 (Dublin)
Founder / CEO: Dr. Nora Khaldi
Notable tech: Proprietary Magnifier (NπΦ) AI platform for peptide discovery
Recent funding: Series C $42M announced Dec 20, 2024
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Ingredient discovery for health, nutrition and cosmetic applications using AI and genomics to identify bioactive peptides from nature.
Founded
2014
Industry
Biotechnology
Tech Stack
Funding Track Record
42,000,000
Series C announced Dec 20, 2024; participants included McWin Capital Partners, Grosvenor and the European Circular Bioeconomy Fund
45,000,000
Series B announced Nov 11, 2021; participants included Grosvenor (Wheatsheaf Group), ECBF, Vertex and others
Seed round announced Dec 1, 2015 with early investors including Clay Capital, Marc Benioff and Enterprise Ireland
Investor Signal
“Broad institutional and strategic investor base including M&G Investments, Grosvenor Food & AgTech, European Circular Bioeconomy Fund, Cleveland Avenue and multiple strategic corporate and venture investors”